Current clinical and experimental evidence strongly supports a robust connection between insulin resistance and cardiovascular disease, mediated heavily by metabolic syndrome, endothelial dysfunction, and vascular remodeling.
The retrieved literature consistently links insulin resistance, hyperinsulinemia, and metabolic syndrome to pathological changes in the cardiovascular system, such as endothelial dysfunction, arterial stiffness, vascular remodeling, and atherosclerosis. All relevant papers support the claim, and no papers refute it.